Deals
Aspen Is Said to Weigh Infant-Formula Unit Sale to Lactalis
- Africa’s largest drugmaker has reviewed options for business
- Aspen had used infant formula to push into China market
This article is for subscribers only.
Aspen Pharmacare Holdings Ltd. is in talks to sell its infant formula business to French dairy group Lactalis International as Africa’s largest drugmaker seeks to cash in on the division, according to people familiar with the matter.
The business could fetch about $1 billion, said the people, who asked not to be identified because the negotiations are private. A deal could be announced as early as this week, though no final decisions have been made and a rival bidder could still emerge with a last-minute offer, they said.